Associate
Henry Shikani, Ph.D., focuses his practice on patent prosecution, client counseling, post-grant proceedings before the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office (USPTO), patent litigation, and providing opinions in the chemical, pharmaceutical, medical device, biologics and biosimilars, biotechnology, consumer products, software, and business methods fields.
Henry has significant experience in patent prosecution and patent portfolio management, including opinions and counseling and patent mapping and mining. His experience also includes assisting with inter partes review (IPR) trials, interference proceedings, Section 337 proceedings before the International Trade Commission (ITC) and Abbreviated New Drug Application (ANDA) litigations under the Hatch-Waxman Act.
Henry has a wide range of technical experience, including in the areas of neuropathology, infectious diseases, immunotherapy, cell manufacturing and processing, nasal devices, genetics, electrochemical cells, material sciences, software technology in the healthcare fields, networking devices and wireless communication, catalysis, and financial technology. His graduate dissertation focused on characterizing the pathogenesis of cerebral malaria and identifying therapeutic options to treat the neuropathological syndrome. As a graduate researcher at Johns Hopkins University, he worked on determining the pathogenic mechanisms of encephalitic viruses.
In addition to conducting research, Henry served as a teaching assistant and tutor at Albert Einstein College of Medicine for his graduate program's biochemistry, molecular cell biology, and grant writing courses. While in graduate school, he served as a peer and youth mentor for New York City's iMentor program.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.